Quarterly report pursuant to Section 13 or 15(d)

Fair Value Measurements (Details 1)

v3.3.0.814
Fair Value Measurements (Details 1) - USD ($)
9 Months Ended
Sep. 30, 2015
Sep. 30, 2014
Balance, beginning   $ 23
Change in fair value of Teva option   (23)
Estimated fair value of warrants assumed in merger on January 2, 2014   10,475
Estimated fair value of warrants issued in January 2014 common stock sale   $ 3,696
Estimated fair value of warrants exchanged for common shares  
Change in fair value of warrants for the year ended December 31, 2014   $ (6,929)
Balance, ending   $ 7,242
Unobservable Inputs (Level 3) [Member]    
Balance, beginning $ 8,464  
Change in fair value of Teva option  
Estimated fair value of warrants assumed in merger on January 2, 2014  
Estimated fair value of warrants issued in January 2014 common stock sale  
Estimated fair value of warrants exchanged for common shares $ (13,862)  
Change in fair value of warrants for the year ended December 31, 2014 8,494  
Balance, ending $ 3,096